Pharmaceutical & Life Sciences News

California’s Generic Drug Competition Law Gets Second Court Test

July 16, 2020, 9:40 AM

A California law that punishes drugmakers who pay to keep generic competitors off the market faces its second court test after that state fought off a challenge at the district court level.

The U.S. Court of Appeals for the Ninth Circuit Thursday will hear oral argument in a case brought by the Association for Accessible Medicines to block the law, which it says unlawfully regulates interstate commerce. The group is appealing a lower court ruling that rejected its bid to stop the law from taking effect in January.

For California Attorney General Xavier Becerra, at stake is whether the state...

To read the full article log in. To learn more about a subscription click here.